ti.\*:(%22Dysfonctionnements biologiques dans les stations d%27%C3%A9puration en boues activ%C3%A9es%22)
Results 1 to 25 of 779480
Selection :
Theoretical study of C3, C3- and C3+RAGHAVACHARI, K.Chemical physics letters. 1990, Vol 171, Num 3, pp 249-253, issn 0009-2614, 5 p.Article
C3 alleles in diseases associated with C3 activationWELCH, T. R; BERRY, A.Disease markers. 1987, Vol 5, Num 2, pp 81-87, issn 0278-0240Article
C3 ACTIVATOR IN AGAMMAGLOBULINEMIA.NAKAJIMA S; NIHEI K; HYODO Y et al.1978; INTERNATION. ARCH. ALLERGY APPL. IMMUNOL.; SWITZ.; DA. 1978; VOL. 56; NO 6; PP. 563-565; BIBL. 6 REF.Article
Human complement component C3: characterization of active C3 S and C3 F, the two common genetic variantsBEHRENDT, N.Molecular immunology. 1985, Vol 22, Num 8, pp 1005-1008, issn 0161-5890Article
Glomérulopathies à C3 = C3 glomerulopathyCHAUVET, Sophie; SERVAIS, Aude; FREMEAUX-BACCHI, Véronique et al.Néphrologie & thérapeutique. 2014, Vol 10, Num 2, pp 78-85, issn 1769-7255, 8 p.Article
C3 NEPHRITIC FACTOR STABILIZATION OF THE CLASSIC C3 CONVERTASE A ROLE FOR C2 IN C3 NEPHRITIC FACTOR ACTIVITYMCEAN RH; NILSON SH.1979; PROC. SOC. EXPER. BIOL. MED.; USA; DA. 1979; VOL. 161; NO 3; PP. 358-363; BIBL. 20 REF.Article
Les dispositions préventives des problèmes biologiques en boues activées = The measures to prevent activated sludge from biological malfunctionDUCHENE, P.Dysfonctionnements biologiques dans les stations d'épuration en boues activées. 1994, 9 p.Conference Paper
Dysfonctionnements biologiques dans les stations d'épuration en boues activées = Biological dysfunctionings in activated sludge facilitiesBALLAY, D; DUCHENE, P; SACHON, G et al.Dysfonctionnements biologiques dans les stations d'épuration en boues activées. 1994, 82 p.Conference Proceedings
Participation of C3 and its ligands in complement activationVOLANAKIS, J. E.Current Topics in Microbiology and Immunology. 1990, Vol 153, pp 1-21, issn 0070-217XArticle
Activation and binding of C3 by Candida albicansKOZEL, T. R; BROWN, R. R; PFROMMER, G. S. T et al.Infection and immunity. 1987, Vol 55, Num 8, pp 1890-1894, issn 0019-9567Article
Activated C3 (C3b) in the nephritic glomerulusPAN, C; STRIFE, C. F; MCADAMS, A. J et al.Pediatric nephrology (Berlin, West). 1993, Vol 7, Num 4, pp 379-386, issn 0931-041XArticle
Actes du deuxième colloque C3, Angoulême, 20-22 mai 1987 = Proceedings of the second workshop C3, Angoulème, May 20-22, 1987ARNOLD, A.Colloque C3. 2. 1987, 397 p.Conference Proceedings
Alkylation des C3/C4 = C3/C4 alkylationHELDER, Y.Pétrole et techniques. 1985, Num 314, pp 16-20, issn 0152-5425Article
THE BINDING OF ACTIVATED C3 TO POLYSACCHARIDES AND IMMUNOGLOBULINSCAPEL PJA; GROENEBOER O; GROSVELD G et al.1978; J. IMMUNOL.; USA; DA. 1978; VOL. 121; NO 6; PP. 2566-2572; BIBL. 22 REF.Article
Pseudosubluxación C2-C3 = Pseudosubluxation of C2-C3RODRIGUEZ VIVAS, C; MANGAS RAMIREZ, S; CANADAS ESPINOSA, F. J et al.Anales de pediatria (2003. Ed. impresa). 2010, Vol 73, Num 4, pp 211-212, issn 1695-4033, 2 p.Article
HOMOZYGOUS C3 DEFICIENCY: DETECTION OF C3 BY RADIOIMMUNOASSAY.DAVIS AE III; DAVIS JS IV; RABSON AR et al.1977; CLIN. IMMUNOL. IMMUNOPATHOL.; U.S.A.; DA. 1977; VOL. 8; NO 3; PP. 543-550; BIBL. 25 REF.Article
Complement-fragment C 3 d im Plasma von Patienten mit chronischer Polyarthritis = Fraction C3 d du complément dans le plasma de sujets atteints de polyarthrite rhumatoïde = Complement fragment C3 d in plasma from patients with chronic rheumatoid arthritisSTANNAT, S; PETER, H. H; RASPE, H. H et al.Zeitschrift für Rheumatologie (Print). 1986, Vol 45, Num 2, pp 47-51, issn 0340-1855Article
Mousses biologiques : influence des surnageants de silos à boues = Biological foaming : influence of returned supernatants from liquid sludge storage tanksLARIGAUDERIE, A; NAULEAU, F.Dysfonctionnements biologiques dans les stations d'épuration en boues activées. 1994, 7 p.Conference Paper
ALTERNATE C3 PATHWAY ACTIVATION IN PNEUMOCOCCAL GLOMERULONEPHRITIS = VOIE ALTERNE D'ACTIVATION DU C3 DANS LA GLOMERULONEPHRITE PNEUMOCOCCIQUEHYMAN LR; JENIS EH; HILL GS et al.1975; AMER. J. MED.; U.S.A.; DA. 1975; VOL. 58; NO 6; PP. 810-814; BIBL. 24 REF.Article
PERFORMANCES ET LIMITES DE LA DESHYDRATATION DES BOUES DE STATIONS D'EPURATION BIOLOGIQUES. ETUDE STATISTIQUEREUTER J.1981; EAU IND.; ISSN 0337-9329; FRA; DA. 1981; NO 60; PP. 77-82Article
Distinctive expression of neoantigenic C3 (D) epitopes on bound C3 following activation and binding to different target surfaces in normal and pathological human seraNILSSON, B; EKDAHL, K. N; SVENSSON, K.-E et al.Molecular immunology. 1989, Vol 26, Num 4, pp 383-390, issn 0161-5890, 8 p.Article
C3 DeficienciesBITTER-SUERMANN, D; BURGER, R.Current Topics in Microbiology and Immunology. 1990, Vol 153, pp 223-233, issn 0070-217XArticle
Photosynthetic pathway-related ultrastructure of C3,C4 and C3-like C3-C4 intermediate sedges (Cyperaceae), with special reference to EleocharisBRUHL, J. J; PERRY, S.Australian journal of plant physiology. 1995, Vol 22, Num 4, pp 521-530, issn 0310-7841Article
Immunoglobulinas e C3 no granuloma paracoccidióidico = Immunoglobulines et complément C3 dans le granulome paracoccidioïdien = Immunoglobulins and C3 in the Paracoccidioides brasiliensis granulomaBIAGIONI, L. M. V; ORSI, S; CHAMMA, L. G et al.Revista do Instituto de Medicina Tropical de São Paulo. 1987, Vol 29, Num 2, pp 97-103, issn 0036-4665Article